← Leaderboards
Susan C. Baker
Loyola University Chicago
$11,375,181
Attributed
$14,772,335
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $854.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,772,335 · 6
By mechanism
R01$12,311,132 · 3
P01$2,019,478 · 1
R21$436,725 · 1
R13$5,000 · 1
Top collaborators
- Andrew D Mesecar10 shared
Others in their field
Top investigators on “Replicase”
- Mark R Denison · Vanderbilt University$17,372,299
- Ralph S Baric · University Of North Carolina Chapel Hill$16,424,399
- Donghoon Chung · University Of Tennessee Health Sci Ctr$13,229,816
- Timothy Patrick Sheahan · Rockefeller University$9,666,597
- Steven E Ealick · Hauptman-Woodward Medical Research Inst$9,505,049
- Susan R. Weiss · University Of Pennsylvania$7,696,255
Research focus
ReplicasePathogenesisVirusVaccinesRna VirusesVirus ReplicationViralImmune ResponseStructureDisease OutbreaksAnimalsKineticsProteinsMutationResponseComplexCellsAntiviral AgentsSevere Acute Respiratory SyndromeFamilyPandemic DiseaseCoronavirus InfectionsPolyproteinsDesign
Grant awards (30)
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2$732,439
R01 · FY2025 · AI · contact PI
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2$739,638
R01 · FY2024 · AI · contact PI
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2$114,248
R01 · FY2024 · AI · contact PI
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2$749,247
R01 · FY2023 · AI · contact PI
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2$105,498
R01 · FY2023 · AI · contact PI
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2$750,461
R01 · FY2022 · AI · contact PI
Investigating Interferon Antagonists in Delaying Innate Immune Responses to SARS-CoV-2$789,887
R01 · FY2021 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$705,182
R01 · FY2019 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$715,409
R01 · FY2018 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$730,847
R01 · FY2017 · AI · contact PI
Nido2017: International Nidovirus Symposium$5,000
R13 · FY2017 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$741,213
R01 · FY2016 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$765,583
R01 · FY2015 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$602,456
R01 · FY2014 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$712,986
R01 · FY2013 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$602,456
R01 · FY2012 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$603,560
R01 · FY2011 · AI · contact PI
Mechanisms of viral proteases in coronavirus replication and pathogenesis$614,617
R01 · FY2010 · AI · contact PI
Identifying Therapeutic Targets in SARS-CoV Replicase$437,853
P01 · FY2009 · AI · contact PI
Bronchial Epithelial Cultures and Kawasaki Disease$192,230
R21 · FY2009 · HL · contact PI
Identifying Therapeutic Targets in SARS-CoV Replicase$425,409
P01 · FY2008 · AI · contact PI
Bronchial Epithelial Cultures and Kawasaki Disease$244,495
R21 · FY2008 · HL · contact PI
Identifying Therapeutic Targets in SARS-CoV Replicase$411,254
P01 · FY2007 · AI · contact PI
Identifying Therapeutic Targets in SARS-CoV Replicase$376,810
P01 · FY2006 · AI · contact PI
Identifying Therapeutic Targets in SARS-CoV Replicase$368,152
P01 · FY2005 · AI
STRUCTURE AND FUNCTION OF THE CORONAVIRUS REPLICASE$266,000
R01 · FY2005 · AI
STRUCTURE AND FUNCTION OF THE CORONAVIRUS REPLICASE$402,937
R01 · FY2004 · AI
STRUCTURE AND FUNCTION OF THE CORONAVIRUS REPLICASE$334,468
R01 · FY2003 · AI
STRUCTURE AND FUNCTION OF THE CORONAVIRUS REPLICASE$266,000
R01 · FY2002 · AI
STRUCTURE AND FUNCTION OF THE CORONAVIRUS REPLICASE$266,000
R01 · FY2001 · AI